The Tobacco Regulatory Science Program (TRSP) is an interagency partnership between the NIH and the FDA Center for Tobacco Products to foster tobacco regulatory research.
With the passage of the 2009 Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act), the FDA acquired the authority to regulate the manufacture, marketing, and distribution of tobacco products in order to protect public health. Within the framework of the Tobacco Control Act, the NIH and FDA formed this partnership to establish a comprehensive research agenda in tobacco regulatory science.
Current K, R01, and R21 funding announcements for career development awards, secondary analysis of existing datasets and biospecimens, and pharmacokinetics of tobacco products. Frequently asked questions and recorded pre-application webinars are available for select funding opportunities.
TRSP encourages research applications that address the FDA's research priorities to better understand toxicity, addiction, and appeal of tobacco products.
The FDA is seeking public comments on their proposed recommendations for designing and conducting tobacco product perception and intention (TPPI) studies that may be submitted as part of a tobacco product application. Comments may be submitted until December 28, 2020.
An NIH-FDA partnership to foster tobacco regulatory research.
Research projects on tobacco regulatory research funded through TRSP.
Active funding announcements and application information.
Research topic and project priorities for TRSP funding announcements.
Research tools, publications, statistics, and announcements.